Innate Pharma S.A. (IPHA)
NASDAQ: IPHA · Real-Time Price · USD
1.560
-0.120 (-7.14%)
Nov 21, 2024, 1:15 PM EST - Market open
Innate Pharma Employees
Innate Pharma had 179 employees as of December 31, 2023. The number of employees decreased by 32 or -15.17% compared to the previous year.
Employees
179
Change (1Y)
-32
Growth (1Y)
-15.17%
Revenue / Employee
$202,250
Profits / Employee
-$203,830
Market Cap
129.75M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Cibus | 183 |
TriSalus Life Sciences | 112 |
Cabaletta Bio | 103 |
Compugen | 68 |
Candel Therapeutics | 42 |
Zentek | 24 |
Avalo Therapeutics | 19 |
Context Therapeutics | 5 |
IPHA News
- 1 day ago - Innate Pharma Releases Its 2025 Financial Calendar - Business Wire
- 2 days ago - Innate Pharma Announces Publication in Science Immunology Highlighting Innovative Next-generation ANKET® IPH6501 - Business Wire
- 8 days ago - Innate Pharma S.A. (IPHA) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 8 days ago - Innate Pharma Reports Third Quarter 2024 Business Update and Financial Results - Business Wire
- 13 days ago - Innate Pharma Highlights Data From Its Innovative Oncology Portfolio Selected for the SITC Annual Meeting 2024 - Business Wire
- 14 days ago - Innate Pharma Announces Conference Call and Webcast for Third Quarter 2024 Results and Business Updates - Business Wire
- 23 days ago - Innate Pharma Announces Its Participation in Upcoming Investor Conferences - Business Wire
- 5 weeks ago - Innate Pharma Appoints Jonathan Dickinson as New Chief Executive Officer and Chairman of the Executive Board - Business Wire